Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Aldrich

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Review of Vaccines|September 23, 2006
Suppressor of cytokine signaling 1 inhibition strategy to enhance anti-HIV vaccinationXiao-Tong Song, Melissa Aldrich, Si-Yi Chen
Vaccine|January 29, 2008
SOCS1 downregulation in dendritic cells promotes memory T-cell responsesMelissa Aldrich, Denise Sanders, Natasha Lapteva, et al.
Medical Oncology (Northwood, London, England)|September 5, 2024
Current diagnostic and quantitative techniques in the field of lymphedema management: a critical reviewMary Vargo, Melissa Aldrich, Paula Donahue, et al.
The Journal of Clinical Investigation|December 17, 2005
SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signalingKevin Evel-Kabler, Xiao-Tong Song, Melissa Aldrich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunityNatalia Lapteva, Melissa Aldrich, David Weksberg, et al.
Frontiers in Medicine|October 2, 2023
Dermatological concerns for women and girls with turner syndromeDavid Rodriguez-Buritica, Meaghan Mones, Siddharth K Prakash, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2009
Attraction and activation of dendritic cells at the site of tumor elicits potent antitumor immunityNatalia Lapteva, Melissa Aldrich, Lisa Rollins, et al.
Plos Medicine|December 31, 2005
An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cellsXiao-Tong Song, Kevin Evel-Kabler, Lisa Rollins, et al.
Plos Biology|December 19, 2008
Twist-2 controls myeloid lineage development and functionAndrew B Sharabi, Melissa Aldrich, Drazen Sosic, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2006
In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiencyDenise A Carbonaro, Xiangyang Jin, Denise Petersen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Review of Vaccines|September 23, 2006
Suppressor of cytokine signaling 1 inhibition strategy to enhance anti-HIV vaccinationXiao-Tong Song, Melissa Aldrich, Si-Yi Chen
Vaccine|January 29, 2008
SOCS1 downregulation in dendritic cells promotes memory T-cell responsesMelissa Aldrich, Denise Sanders, Natasha Lapteva, et al.
Medical Oncology (Northwood, London, England)|September 5, 2024
Current diagnostic and quantitative techniques in the field of lymphedema management: a critical reviewMary Vargo, Melissa Aldrich, Paula Donahue, et al.
The Journal of Clinical Investigation|December 17, 2005
SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signalingKevin Evel-Kabler, Xiao-Tong Song, Melissa Aldrich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunityNatalia Lapteva, Melissa Aldrich, David Weksberg, et al.
Frontiers in Medicine|October 2, 2023
Dermatological concerns for women and girls with turner syndromeDavid Rodriguez-Buritica, Meaghan Mones, Siddharth K Prakash, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2009
Attraction and activation of dendritic cells at the site of tumor elicits potent antitumor immunityNatalia Lapteva, Melissa Aldrich, Lisa Rollins, et al.
Plos Medicine|December 31, 2005
An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cellsXiao-Tong Song, Kevin Evel-Kabler, Lisa Rollins, et al.
Plos Biology|December 19, 2008
Twist-2 controls myeloid lineage development and functionAndrew B Sharabi, Melissa Aldrich, Drazen Sosic, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2006
In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiencyDenise A Carbonaro, Xiangyang Jin, Denise Petersen, et al.
Pageof 2